KR101413939B1 - 펩타이드가 결합된 아스코르빈산 유도체 - Google Patents

펩타이드가 결합된 아스코르빈산 유도체 Download PDF

Info

Publication number
KR101413939B1
KR101413939B1 KR1020070105843A KR20070105843A KR101413939B1 KR 101413939 B1 KR101413939 B1 KR 101413939B1 KR 1020070105843 A KR1020070105843 A KR 1020070105843A KR 20070105843 A KR20070105843 A KR 20070105843A KR 101413939 B1 KR101413939 B1 KR 101413939B1
Authority
KR
South Korea
Prior art keywords
ascorbic acid
peptide
skin
amino acid
whitening
Prior art date
Application number
KR1020070105843A
Other languages
English (en)
Korean (ko)
Other versions
KR20090040187A (ko
Inventor
이윤식
김한영
노진미
Original Assignee
재단법인서울대학교산학협력재단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 재단법인서울대학교산학협력재단 filed Critical 재단법인서울대학교산학협력재단
Priority to KR1020070105843A priority Critical patent/KR101413939B1/ko
Priority to PCT/KR2008/006204 priority patent/WO2009051460A2/fr
Publication of KR20090040187A publication Critical patent/KR20090040187A/ko
Application granted granted Critical
Publication of KR101413939B1 publication Critical patent/KR101413939B1/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
KR1020070105843A 2007-10-20 2007-10-20 펩타이드가 결합된 아스코르빈산 유도체 KR101413939B1 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020070105843A KR101413939B1 (ko) 2007-10-20 2007-10-20 펩타이드가 결합된 아스코르빈산 유도체
PCT/KR2008/006204 WO2009051460A2 (fr) 2007-10-20 2008-10-20 Dérivés d'acide ascorbique couplés à un peptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020070105843A KR101413939B1 (ko) 2007-10-20 2007-10-20 펩타이드가 결합된 아스코르빈산 유도체

Publications (2)

Publication Number Publication Date
KR20090040187A KR20090040187A (ko) 2009-04-23
KR101413939B1 true KR101413939B1 (ko) 2014-06-30

Family

ID=40567994

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020070105843A KR101413939B1 (ko) 2007-10-20 2007-10-20 펩타이드가 결합된 아스코르빈산 유도체

Country Status (2)

Country Link
KR (1) KR101413939B1 (fr)
WO (1) WO2009051460A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160143901A (ko) * 2015-06-04 2016-12-15 주식회사 크릴랜드 하이브리드 아스코르빈산 유도체 및 그 제조방법
WO2022031044A1 (fr) * 2020-08-05 2022-02-10 주식회사 레미바이오 Dérivé de l'acide ascorbique et composition le comprenant

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101594559B1 (ko) * 2008-09-25 2016-02-18 코닌클리케 필립스 엔.브이. 조정된 채널 선택을 갖는 방향성 탐색 프로토콜
KR101154233B1 (ko) * 2010-02-11 2012-06-18 성민규 타이로신 유도체를 함유하는 미백용 화장료 조성물
EP3092220B1 (fr) * 2013-09-25 2021-01-20 University of Florida Research Foundation, Inc. Promédicaments de la vitamine c et leurs utilisations
SG11201704321TA (en) * 2014-11-27 2017-06-29 Celltrion Inc Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition comprising same
KR101969345B1 (ko) * 2016-05-26 2019-04-16 (주)셀트리온 펩타이드가 결합된 안정한 아스코르빈산 유도체를 포함하는 피부 염증 완화용 조성물
KR102101329B1 (ko) * 2018-01-18 2020-04-17 주식회사 라모수 중금속 제거능을 갖는 아스코르빈산 유도체의 제조 방법
KR102130701B1 (ko) * 2018-09-27 2020-07-06 주식회사 차메디텍 비타민 c가 결합된 펩타이드 유도체 및 이를 포함하는 조성물
CN110183432B (zh) * 2019-06-28 2021-08-31 珠海市柏瑞医药科技有限公司 一种5,6-o-异亚丙基-l-抗坏血酸的制备工艺
CN113087899B (zh) * 2021-03-30 2023-03-07 山东丰金生物工程有限公司 一种l-抗坏血酸衍生物及其制备方法、应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56161314A (en) * 1980-05-15 1981-12-11 Pola Chem Ind Inc Cosmetic for lightening the color of facial skin
WO1996040647A1 (fr) 1995-06-07 1996-12-19 Prototek, Inc. α-(1,3-DICARBONYLENOL ETHER) METHYLE CETONES UTILISEES COMME INHIBITEURS DE LA CYSTEINE PROTEASE
US20050075316A1 (en) 2002-07-29 2005-04-07 Lockwood Samuel Fournier Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56161314A (en) * 1980-05-15 1981-12-11 Pola Chem Ind Inc Cosmetic for lightening the color of facial skin
WO1996040647A1 (fr) 1995-06-07 1996-12-19 Prototek, Inc. α-(1,3-DICARBONYLENOL ETHER) METHYLE CETONES UTILISEES COMME INHIBITEURS DE LA CYSTEINE PROTEASE
US20050075316A1 (en) 2002-07-29 2005-04-07 Lockwood Samuel Fournier Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160143901A (ko) * 2015-06-04 2016-12-15 주식회사 크릴랜드 하이브리드 아스코르빈산 유도체 및 그 제조방법
KR101724409B1 (ko) 2015-06-04 2017-04-11 주식회사 크릴랜드 하이브리드 아스코르빈산 유도체 및 그 제조방법
WO2022031044A1 (fr) * 2020-08-05 2022-02-10 주식회사 레미바이오 Dérivé de l'acide ascorbique et composition le comprenant

Also Published As

Publication number Publication date
WO2009051460A2 (fr) 2009-04-23
KR20090040187A (ko) 2009-04-23
WO2009051460A3 (fr) 2010-07-15

Similar Documents

Publication Publication Date Title
KR101413939B1 (ko) 펩타이드가 결합된 아스코르빈산 유도체
US11331305B2 (en) Peptides for skin rejuvenation and methods of using the same
JPH05503939A (ja) 抗―酸化及び抗―炎症性金属：ペプチド複合体及びその使用
US20130252903A1 (en) Compositions for reducing oxidative stress and uses thereof
MX2010009485A (es) Composiciones farmaceuticas o cosmeticas que comprenden inhibidores de metaloproteinasa.
FR2998570A1 (fr) Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes
DE10341654A1 (de) Mittel zur Anwendung auf der Haut und/oder dem Haar enthaltend 4-fach substituierte Cyclohexen-Verbindungen
TW201018492A (en) Peptides useful in the treatment and/or care of skin, mucous membranes, scalp and/or hair and their use in cosmetic or pharmaceutical compositions
FR3029782A1 (fr) Composes peptidiques, compositions les comprenant et utilisations notamment cosmetiques
WO2008045272A2 (fr) Compositions et procédés éclaircissante pour la peau
KR101516074B1 (ko) 폴리다틴과 트라넥삼산을 유효성분으로 포함하는 피부 미백용 조성물
WO2007148831A1 (fr) Promoteur de synthèse du collagene contenant un sel de zinc en tant qu'ingrédient actif
JP2024075684A (ja) 皮膚症状を改善するためのポリペプチドおよび方法
KR20110012148A (ko) 펩타이드가 결합된 하이드록시 시나믹산 유도체, 이의 제조 방법 및 이를 포함하는 화장품 조성물
JP4892060B2 (ja) ペプチドが結合された安定化ビタミンｃ誘導体、その製造方法、およびこれを含む組成物
KR101763933B1 (ko) 페놀릭산 유도체 및 이를 포함하는 화장품 조성물
DE10341663A1 (de) Haut- und/oder Haarmittel enthaltend 4-fach substituierte Cyclohexen-Verbindungen
KR20130108828A (ko) 올리고펩타이드를 포함하는 피부 미백용 조성물
TWI675849B (zh) 化合物或其美容學上可接受的鹽用於減少皺紋之用途
KR101511252B1 (ko) 백출추출물과 트라넥삼산을 유효성분으로 포함하는 피부 미백용 조성물
EP3485871A1 (fr) Inhibiteur de la production de mélanine, agent d'éclaircissement de la peau, activateur des fibroblastes, promoteur de la production du collagène et/ou de l'élastine, et agent d'amélioration des rides
WO2000064926A1 (fr) Inhibiteur hormonal stimulant les melanocytes
JP5423002B2 (ja) 亜鉛を有効成分として含有するコラーゲン合成促進剤
FR2753707A1 (fr) Complexes nucleopeptidiques, compositions cosmetologiques et pharmaceutiques les contenant et utilisations
Kukowska et al. Developments in the synthesis and biological activity of Glycyl-LHistydyl-L-Lysine derivatives

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20160224

Year of fee payment: 6